Form 4: Ameren SVP Sells 3,000 Shares Under 10b5-1 Plan

Ajay K. Arora, SVP of a subsidiary at Ameren Corp (AEE), reported the sale of 3,000 shares of common stock at $111.44 per share.

Summary

• Ajay K. Arora, identified as an SVP of a subsidiary of Ameren Corp (AEE), reported a transaction.
• The transaction involved the disposition (sale) of 3,000 shares of Ameren Common Stock, $.01 Par Value.
• The sale occurred on February 17, 2026, at a price of $111.44 per share.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.
• Following the reported transaction, Arora directly owns 16,534 shares of common stock.
• Indirect beneficial ownership includes 21,037 shares held by a family trust and an estimated 1,716 share equivalents in a 401(k) plan as of January 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction, likely for personal financial management, and is mitigated by being executed under a pre-arranged 10b5-1 plan.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under a Rule 10b5-1 plan, are common for personal financial planning, diversification, or liquidity purposes and do not necessarily reflect a change in management's outlook on the company's prospects. Such plans allow insiders to sell shares at pre-determined times or prices to avoid accusations of trading on material non-public information.

Stakeholder Impact

• Shareholders: May observe the insider sale, but given it's a 10b5-1 plan and a relatively small amount for a large company, the impact on sentiment is likely minimal.

Key Dates

Recommendation

The sale of 3,000 shares by a subsidiary SVP, while an insider transaction, is a relatively small amount compared to Ameren's overall market capitalization and is executed under a pre-planned 10b5-1 arrangement. This type of transaction typically does not signal a significant change in the company's fundamentals or warrant a strong buy or sell recommendation, thus a 'hold' stance is appropriate.

Keywords

Ameren, AEE, insider sale, Form 4, executive transaction, 10b5-1 plan, common stock